Archive

Self-owned brands, especially in anti-infectives, lifestyle diseases, dermatology and neurology, to get a major boost

The US Food and Drug Administration has approved Zydelig (idelalisib) to treat patients with three types of blood cancers

Consolidated net profit increases by 43.65 per cent

To offer bioequivalence studies for generic pharma and late phase patient-based clinical studies for research-based companies

The Mumbai market grew the highest at 24.3 per cent followed by Vidarbha at 21.3 per cent

It will be held in Mumbai from October 16-18, 2014; the theme for the event will be ‘The Future of Indian Healthcare: Patients,…

IDMA briefing on impact of Mumbai HC order quashing FSSAI advisory

Include minimum pay equivalent to primary teacher or junior engineer

The company has posted profit after tax at Rs 5.5 billion

To launch the CE Marked OneDose ReadyfusOR pre-filled with Ropivacaine under its own label into the German market late this year